Behnam Ebrahimi, M.D.
Behnam Ebrahimi, M.D.
, was inspired early by his father, who worked as a pediatrician both in their home country of Iran and in the U.S.
Ebrahimi would shadow his dad around the doctor’s office when he was growing up, and those early experiences piqued his interest in the power of medicine to help people suffering from illness, and of science to uncover new treatment options.
Hope on the Horizon
Ebrahimi’s family settled in the Los Angeles area when he was a teenager, and after completing his undergraduate degree at UCLA, he moved to Houston to study molecular biology and earn his doctorate at Baylor College of Medicine.
At the time, you could see a hint of what was on the horizon in oncology, which would lead to the exciting developments in precision medicine and immunotherapies we see today,” Ebrahimi explained. “The challenge of the field and the rapid development of the science is what first drew me to oncology.”
After completing his doctorate, Ebrahimi entered into a hematology/oncology fellowship at the University of Texas’s MD Anderson Cancer Center, where he was selected as chief fellow and awarded a National Cancer Institute Fellowship Research Grant.
“While I was at MD Anderson, I picked gastrointestinal (GI) malignancies as my track,” Ebrahimi said. “My mentor there had an interest in pancreatic cancer
, and together we wrote a book, 'Myths and Facts about Pancreatic Cancer,' to help patients understand and navigate this deadly type of cancer.”
World-class Community Care
As a medical oncologist at City of Hope’s Rancho Cucamonga location
, Ebrahimi treats a wide range of cancer types, but he has also maintained his interest in GI malignancies like colon
and pancreatic cancers
, regularly attending meetings and publishing articles on these conditions throughout his career.
Ebrahimi likes the fact that City of Hope in Rancho Cucamonga offers a small community setting, where he can work closely with his patients and their families.
We’re able to bring state-of-the-art medicine to our community,” he said.
A Vital Tool
That state-of-the-art medicine includes clinical trials
, which Ebrahimi believes are a vital tool for patients dealing with cancer today, potentially offering alternate treatment options and hope to patients whose cancers don’t have good treatment options otherwise.
“We currently have about 35 trials open in Rancho, and we’re always working to increase access for our patients,” he said. “We try to open up trials that offer the standard treatment plus something novel. What that does is expand the treatment options for our patients.”
Beyond the leading-edge research available at City of Hope, Ebrahimi enjoys being part of a center renowned for its multidisciplinary care across a wide range of specialties and expertise. “First and foremost, my number one priority is caring for patients and their families," he said. “And City of Hope really provides an environment where I can do that.”
, Thank you for supporting our mission of eliminating cancer and other life-threatening diseases! Make sure to check your inbox from time to time for the latest City of Hope updates and breakthroughs.